
Multiple Myeloma Patient Symposium
Dana-Farber Cancer Institute
Updates on AL Amyloidosis Treatment: What’s New in 2024
FEATURING
Giada Bianchi
- 192 views
- July 2, 2024
Dana-Farber Cancer Institute
Multiple Myeloma 101: Diagnosis, Prognosis, and Risk
FEATURING
Paul Richardson
- 736 views
- July 2, 2024
- 5
Dana-Farber Cancer Institute
CAR T-Cells in Multiple Myeloma in 2024
FEATURING
Adam Sperling
- 279 views
- July 2, 2024
- 4
Dana-Farber Cancer Institute
Updates in the Management of SMM/MGUS and the Prevention of Progression
FEATURING
Yuxin Liu
- 92 views
- July 2, 2024
Dana-Farber Cancer Institute
Bispecific Antibody Therapy in Multiple Myeloma
FEATURING
Shonali Midha
- 73 views
- July 1, 2024
- 2
Dana-Farber Cancer Institute
Advances in Multiple Myeloma 2024: From Bench to Bedside
FEATURING
Kenneth Anderson
- 708 views
- July 1, 2024
- 5
Dana-Farber Cancer Institute
Future of Novel Next Generation Therapy in the Management of R/R MM
FEATURING
Paul Richardson
- 226 views
- June 18, 2024
- 3
Dana-Farber Cancer Institute
Continued Evolution of Therapy for Patients With Newly Diagnosed MM
FEATURING
Clifton Mo
- 145 views
- June 10, 2024
- 2